ANTI-PD-1 AND ANTI-PD-L1 ANTIBODIES AS IMMUNOTHERAPY AGAINST CANCER: A STRUCTURAL PERSPECTIVE

Cordova-Bahena, L; Velasco-Velazquez, MA

Velasco-Velazquez, MA (corresponding author), Univ Autonoma Mexico UNAM, Fac Med, Dept Pharmacol, Mexico City, DF, Mexico.; Velasco-Velazquez, MA (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Peripheral Res Unit Translat Biomed, Mexico City, DF, Mexico.; Velasco-Velazquez, MA (corresponding author), Inst Seguridad & Serv Sociales Trabajadores, Ctr Med Nacl Noviembre 20, Mexico City, DF, Mexico.

REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021; 73 (1): 8

Abstract

Programmed cell death protein 1 (PD-1) and its ligand, programmed death-ligand-1 (PD-L1), play key roles in the suppression of the cytotoxic activity ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索